Atlas Trials

A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers

Clinical trial NCT02429232 · UNKNOWN

Trial details

NCT number
NCT02429232
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
OsteoporosisDiabetes Mellitus
Start date
2015-10-01
Primary completion
2017-07-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.